Saturday 17 October 2026 Export KPTI’s income statement to Excel — free account

Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $146.1 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 11.9%, EPS grew 46.3%, free cash flow fell 33.3% and total debt rose 36.6%, each against the same quarter a year earlier.

0.39 0.04 +11.43%

Follow KPTI

Alert me

Market cap: $8.0M
P/E: 0.0×
Fwd P/E: −2.1×
Dividend yield: —
F-score: 3/9
Altman Z: −23.89
Beneish M: −8.05
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	58.11%	81.86%	82.70%	78.98%
Piotroski F-Score Full definition →		3	3	2	2
ROA Full definition →		(87.24%)	(143.71%)	(150.48%)	(207.90%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(4,596.86%)	(1,751.91%)	(2,137.35%)	809.55%
Average Days of Receivables Full definition →		81.63	65.42	56.41	74.36
Free Cash Flow per Share Full definition →		(10.31)	(6.89)	(2.69)	(2.26)
Free Cash Flow Full definition →		(89.35)	(75.37)	(59.11)	(65.35)
Other line items
Cash ROIC Full definition →		263.67%	3,295.54%	(119.20%)	432.13%
Accounts Receivable Turnover Full definition →		4.48	5.13	5.16	4.67
Accounts Payable Turnover Full definition →		1.04	1.31	1.18	1.18
Inventory Turnover Full definition →		1.34	1.36	1.43	1.34
Average Days of Payables Full definition →		339.56	245.60	260.61	463.90
Days of Inventory on Hand Full definition →		249.76	247.75	219.19	241.88
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		92.09%	86.00%	82.58%	82.50%
Selling, General and Administrative Expense of Revenue Full definition →		76.91%	72.03%	69.18%	69.55%
Share Based Compensation of Revenue Full definition →		9.83%	9.62%	8.93%	7.94%
Interest Coverage Full definition →		(2.34)	(1.98)	(1.78)	(1.67)
Operating CF/Net income Full definition →		0.72	0.38	0.30	0.29
Depreciation/Fixed assets Full definition →		82.16	100.31	114.21	108.29
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		16.44	13.36	6.86	5.07
Operating CF per Share Full definition →		(10.31)	(6.89)	(2.69)	(2.26)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly